AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 32 min read$CTS

O'SULLIVAN KIERAN M sold $1.5M of CTS

O'SULLIVAN KIERAN M (President & CEO) sold 22,657 shares of CTS CORP (CTS) at $66.67 ($1.51M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · O'SULLIVAN KIERAN M
Published Jun 3, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CTS
Neutral
medium confidence
Mentioned
$CTS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSNeutralLow
01

Why it matters

The disclosure may slightly influence short-term sentiment, but it is unlikely to change valuation drivers absent accompanying operational/financial news.

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing alone is not a strong catalyst.

03

What to watch

The filing does not provide the CEO’s rationale, and 10b5-1 sales are often scheduled for tax/compensation liquidity rather than signaling.

Relevance 6/10Novelty 2/10Timing: Filed on 2026-06-03 (same day as the reported sale date).

Background

This is an SEC Form 4 insider transaction: CTS Corp’s President & CEO sold shares via an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$CTSNeutralMedium confidence
Context

CTS Corp CEO sold 22,657 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-03.

Expected impact

Likely limited/short-lived impact; any move would be small and sentiment-driven rather than fundamental.

Evidence & confidence

The filing is an ownership-change disclosure with a stated pre-arranged 10b5-1 plan, which reduces the signal strength versus discretionary selling.

Market effects

Sector

No sector-wide read-through; this is company-specific insider transaction disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with a 10b5-1 plan, repeated or large cumulative insider sales can still be interpreted by some traders as reduced confidence.

Key entities

  • issuer
    CTS CORP

    Subject of the SEC Form 4 insider transaction; CEO sold 22,657 shares at ~$66.6708/share.

  • insider
    O'SULLIVAN KIERAN M

    President & CEO who executed the open-market sale under a 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CTS insider trading history →

Related articles

JUL 30
$CTSMedAI 8/10

CTS Corporation Q2 2026 Earnings Call Summary

CTS Corporation reported Q2 2026 gross margin of 41.5% and said diversified end markets now make up 59% of revenue. Medical sales grew 45% YoY, industrial rose 16%, while transportation fell 2%. Full-year 2026 sales guidance was raised to $565-$585 million. Management expects aerospace strength in H2 and cautions on tariffs and precious metal inflation.

yahoo.com6 min
JUL 28
$CTSMedAI 8/10

Why CTS (CTS) Stock Is Up Today

CTS Corporation (NYSE: CTS) shares rose about 5.8% after the company reported Q2 results that beat expectations and raised full-year guidance. CTS said sales were $144.8 million (+7% YoY) and adjusted EPS was $0.74. It now expects 2026 revenue around $575 million (midpoint) and adjusted EPS of $2.63 (midpoint).

financialcontent.com4 min
JUL 28
$CTSHigh

CTS CORP (CTS): Results of Operations and Financial Condition

CTS CORP (CTS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cts-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 July 28, 2026 FOR IMMEDIATE RELEASE CTS Announces Second Quarter 2026 Results Strong diversification momentum drives record margins and profitability; 2026 outlook raised Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading gl

SEC EDGAR 8-K3 min
JUL 24
$CTSMed

ASX Runners of the Week: Ceretas, Pacgold & Hamelin Gold

The article links Middle East tensions to a jump in oil prices, with Brent up about 15% above US$100. It also cites Australia’s June employment gain of 76,300 and unemployment at 4.4%. ASX “runners” include Ceretas Ltd (CTS), up 142% after an $8m IPO for portable ultrasound in Alzheimer’s trials, and Pacgold Ltd (PGO), up 82% after high-grade copper-gold results at White Dam.

theage.com.au6 min